SRPT

Sarepta Therapeutics, Inc. News Headlines

$13.7
*  
0.20
1.48%
Get SRPT Alerts
*Delayed - data as of Dec. 18, 2014 12:54 ET  -  Find a broker to begin trading SRPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    SRPT Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
8 Reasons Why I Expect Molycorp Shares To Double In 1Q 2014
10/3/2013 11:02:00 AM - Seeking Alpha


Is Sarepta Winning?
10/2/2013 5:34:00 PM - Seeking Alpha


Synageva Raises Funds - Analyst Blog
10/1/2013 4:47:36 PM - Zacks.com


Sarepta Shares Continue to Inch Up - Analyst Blog
9/30/2013 3:42:41 PM - Zacks.com


5 Biopharmas With Upcoming Catalysts That Should Rally
9/27/2013 8:01:00 AM - Seeking Alpha


Is It Time To Go Long Sarepta Therapeutics?
9/26/2013 2:34:00 PM - Seeking Alpha


Investors are Betting Against Sarepta Therapeutics Inc. (SRPT) Should You? - Tale of the Tape
9/26/2013 5:32:47 AM - Zacks.com


Synageva Prices Public Offering - Analyst Blog
9/25/2013 4:05:01 PM - Zacks.com


Sarepta Therapeutics: A Bigger Cake Outweighs A Lower Chance For A Party
9/23/2013 3:47:00 PM - Seeking Alpha


Prosensa Collapses on Drug Trial Failure - Analyst Blog
9/23/2013 11:53:08 AM - Zacks.com


Today's Market: Technology, Biotech And Retail Name Moving
9/23/2013 9:40:00 AM - Seeking Alpha


Phase III Trial Ruins Prosensa's Drisapersen, Sarepta Rallies Strongly
9/23/2013 9:30:00 AM - Seeking Alpha


Sarepta Therapeutics (SRPT) Worth Considering: Stock Surges 18.0% - Analyst Blog
9/23/2013 7:36:20 AM - Zacks.com


Market Wrap For Friday, September 20: Market Gives Up Bernanke's Boost
9/20/2013 3:30:55 PM - Benzinga


Mid-Afternoon Market Update: BlackBerry Releases Awful Guidance, Proves Bears Right
9/20/2013 2:44:08 PM - Benzinga


Mid-Day Market Update: US Stocks Drop; TIBCO Shares Surge On Upbeat Results
9/20/2013 11:55:13 AM - Benzinga


Prosensa: One Duchenne Therapy Down
9/20/2013 11:05:00 AM - Seeking Alpha


Pre-Market Most Active for Sep 20, 2013 : RNA, SRPT, JCP, SNY, ALU, SIRI, NOK, FB, JKS, BUD, AAPL, MSFT
9/20/2013 7:40:01 AM - NASDAQ.com News


Sector Update: Healthcare Shares Mixed Pre-Market; Sarepta Sinks 10% on GlaxoSmithKline, Prosensa Study
9/20/2013 7:22:09 AM - MT Newswires


Sector Update: Healthcare
9/20/2013 7:17:31 AM - MT Newswires


Insider Trading: Carl Icahn Sells Shares of WebMD While Sarepta and American Eagle See Purchases
9/19/2013 8:48:00 AM - Minyanville


6 Reasons Advaxis May Be The Best Reward Vs. Risk In Healthcare
9/6/2013 2:47:00 PM - Seeking Alpha


Insiders Are Buying Sarepta Therapeutics
8/25/2013 7:01:00 PM - Seeking Alpha


Don't Miss These 3 Healthcare Sweet Spots
8/24/2013 3:32:00 AM - Seeking Alpha


Positive Data And Investor Interest Uphold Stemline's Momentum
8/19/2013 11:06:00 AM - Seeking Alpha